PKD at the crossroads of DAG and PKC signaling

Trends in Pharmacological Sciences

Volumn 27, Issue 6, 2006, Pages 317-323

  Wang, Qiming J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; DIACYLGLYCEROL; ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE D; PROTEIN KINASE D INHIBITOR; PROTEIN KINASE INHIBITOR; RESVERATROL; RUBOXISTAURIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; CELL FUNCTION; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; DRUG DESIGN; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME STRUCTURE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HEART VENTRICLE HYPERTROPHY; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DIGLYCERIDES; DRUG DESIGN; HUMANS; ISOENZYMES; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 33744926666     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2006.04.003     Document Type: Review

References (63)

1. Newton A.C. Protein kinase C: structural and spatial regulation by phosphorylation, cofactors, and macromolecular interactions. Chem. Rev. 101 (2001) 2353-2364
2. Yang C., and Kazanietz M.G. Divergence and complexities in DAG signaling: looking beyond PKC. Trends Pharmacol. Sci. 24 (2003) 602-608
3. Poole A.W., et al. PKC-interacting proteins: from function to pharmacology. Trends Pharmacol. Sci. 25 (2004) 528-535
4. Rozengurt E., et al. Protein kinase D signaling. J. Biol. Chem. 280 (2005) 13205-13208
5. Valverde A.M., et al. Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 8572-8576
6. Sturany S., et al. Molecular cloning and characterization of the human protein kinase D2. A novel member of the protein kinase D family of serine threonine kinases. J. Biol. Chem. 276 (2001) 3310-3318
7. Hayashi A., et al. PKCν, a new member of the protein kinase C family, composes a fourth subfamily with PKCμ. Biochim. Biophys. Acta 1450 (1999) 99-106
8. Nishikawa K., et al. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J. Biol. Chem. 272 (1997) 952-960
9. Doppler H., et al. A phosphorylation state-specific antibody recognizes Hsp27, a novel substrate of protein kinase D. J. Biol. Chem. 280 (2005) 15013-15019
10. Iglesias T., and Rozengurt E. Protein kinase D activation by mutations within its pleckstrin homology domain. J. Biol. Chem. 273 (1998) 410-416
11. Zugaza J.L., et al. Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway. EMBO J. 15 (1996) 6220-6230
12. Waldron R.T., and Rozengurt E. Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain. J. Biol. Chem. 278 (2003) 154-163
13. Zugaza J.L., et al. Bombesin, vasopressin, endothelin, bradykinin, and platelet-derived growth factor rapidly activate protein kinase D through a protein kinase C-dependent signal transduction pathway. J. Biol. Chem. 272 (1997) 23952-23960
14. Matthews S.A., et al. Protein kinase D. A selective target for antigen receptors and a downstream target for protein kinase C in lymphocytes. J. Exp. Med. 191 (2000) 2075-2082
15. Sturany S., et al. Mechanism of activation of protein kinase D2 (PKD2) by the CCK(B)/gastrin receptor. J. Biol. Chem. 277 (2002) 29431-29436
16. Rey O., et al. Protein kinase Cν/protein kinase D3 nuclear localization, catalytic activation, and intracellular redistribution in response to G protein-coupled receptor agonists. J. Biol. Chem. 278 (2003) 23773-23785
17. Wong C., and Jin Z.G. Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor. J. Biol. Chem. 280 (2005) 33262-33269
18. Waldron R.T., et al. The pleckstrin homology domain of protein kinase D interacts preferentially with the η isoform of protein kinase C. J. Biol. Chem. 274 (1999) 9224-9230
19. Marklund U., et al. Intracellular location and cell context-dependent function of protein kinase D. Immunity 19 (2003) 491-501
20. Storz P., et al. Tyrosine phosphorylation of protein kinase D in the pleckstrin homology domain leads to activation. J. Biol. Chem. 278 (2003) 17969-17976
21. Vantus T., et al. Doxorubicin-induced activation of protein kinase D1 through caspase-mediated proteolytic cleavage: identification of two cleavage sites by microsequencing. Cell. Signal. 16 (2004) 703-709
22. Lemonnier J., et al. Protein kinase C-independent activation of protein kinase D is involved in BMP-2-induced activation of stress mitogen-activated protein kinases JNK and p38 and osteoblastic cell differentiation. J. Biol. Chem. 279 (2004) 259-264
23. Rey O., et al. Rapid protein kinase D translocation in response to G protein-coupled receptor activation. Dependence on protein kinase C. J. Biol. Chem. 276 (2001) 32616-32626
24. Matthews S.A., et al. Spatial and temporal regulation of protein kinase D (PKD). EMBO J. 19 (2000) 2935-2945
25. Rey O., et al. G protein-coupled receptor-mediated phosphorylation of the activation loop of protein kinase D: dependence on plasma membrane translocation and protein kinase Cε{lunate}. J. Biol. Chem. 279 (2004) 34361-34372
26. Oancea E., et al. Mechanism of persistent protein kinase D1 translocation and activation. Dev. Cell 4 (2003) 561-574
27. Rey O., et al. Regulated nucleocytoplasmic transport of protein kinase D in response to G protein-coupled receptor activation. J. Biol. Chem. 276 (2001) 49228-49235
28. Auer A., et al. Role of the regulatory domain of protein kinase D2 in phorbol ester binding, catalytic activity, and nucleocytoplasmic shuttling. Mol. Biol. Cell 16 (2005) 4375-4385
29. Prestle J., et al. Protein kinase Cμ is located at the Golgi compartment. J. Cell Biol. 134 (1996) 1401-1410
30. Maeda Y., et al. Recruitment of protein kinase D to the trans-Golgi network via the first cysteine-rich domain. EMBO J. 20 (2001) 5982-5990
31. Baron C.L., and Malhotra V. Role of diacylglycerol in PKD recruitment to the TGN and protein transport to the plasma membrane. Science 295 (2002) 325-328
32. Liljedahl M., et al. Protein kinase D regulates the fission of cell surface destined transport carriers from the trans-Golgi network. Cell 104 (2001) 409-420
33. Storz P., et al. Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species. Mol. Cell. Biol. 25 (2005) 8520-8530
34. Jamora C., et al. Gβγ-mediated regulation of Golgi organization is through the direct activation of protein kinase D. Cell 98 (1999) 59-68
35. Diaz Anel, A.M. and Malhotra, V. (2005) PKCη is required for β1γ2/β3γ2- and PKD-mediated transport to the cell surface and the organization of the Golgi apparatus. J. Cell Biol. 169, 83-91
36. Hausser A., et al. Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIβ at the Golgi complex. Nat. Cell Biol. 7 (2005) 880-886
37. Prigozhina N.L., and Waterman-Storer C.M. Protein kinase D-mediated anterograde membrane trafficking is required for fibroblast motility. Curr. Biol. 14 (2004) 88-98
38. Woods A.J., et al. PKD1/PKCμ promotes ανβ3 integrin recycling and delivery to nascent focal adhesions. EMBO J. 23 (2004) 2531-2543
39. Qiang Y.W., et al. Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells. Blood 103 (2004) 301-308
40. Bowden E.T., et al. An invasion-related complex of cortactin, paxillin and PKCμ associates with invadopodia at sites of extracellular matrix degradation. Oncogene 18 (1999) 4440-4449
41. Jaggi M., et al. E-cadherin phosphorylation by protein kinase D1/protein kinase Cμ is associated with altered cellular aggregation and motility in prostate cancer. Cancer Res. 65 (2005) 483-492
42. Zhukova E., et al. Protein kinase D potentiates DNA synthesis and cell proliferation induced by bombesin, vasopressin, or phorbol esters in Swiss 3T3 cells. J. Biol. Chem. 276 (2001) 40298-40305
43. Guha S., et al. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1. Cancer Res. 62 (2002) 1632-1640
44. Trauzold A., et al. PKCμ prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells. Oncogene 22 (2003) 8939-8947
45. Celil A.B., and Campbell P.G. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J. Biol. Chem. 280 (2005) 31353-31359
46. Bagowski C.P., et al. Cell-type specific phosphorylation of threonines T654 and T669 by PKD defines the signal capacity of the EGF receptor. EMBO J. 18 (1999) 5567-5576
47. Hurd C., et al. Protein kinase D complexes with C-Jun N-terminal kinase via activation loop phosphorylation and phosphorylates the C-Jun N-terminus. Oncogene 21 (2002) 2154-2160
48. Wang Y., et al. The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins. Mol. Cell. Biol. 22 (2002) 916-926
49. Vega R.B., et al. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol. Cell. Biol. 24 (2004) 8374-8385
50. Dequiedt F., et al. Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis. J. Exp. Med. 201 (2005) 793-804
51. Matthews S.A., et al. Essential role for protein kinase D family kinases in the regulation of class II histone deacetylases in B lymphocytes. Mol. Cell. Biol. 26 (2006) 1569-1577
52. Yang X.J., and Gregoire S. Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol. Cell. Biol. 25 (2005) 2873-2884
53. Storz P., and Toker A. Protein kinase D mediates a stress-induced NF-kB activation and survival pathway. EMBO J. 22 (2003) 109-120
54. Storz P., et al. Protein kinase Cδ selectively regulates protein kinase D-dependent activation of NF-kB in oxidative stress signaling. Mol. Cell. Biol. 24 (2004) 2614-2626
55. Bollag W.B., et al. Protein kinase D and keratinocyte proliferation. Drug News Perspect. 17 (2004) 117-126
56. Jaggi M., et al. Protein kinase Cμ is down-regulated in androgen-independent prostate cancer. Biochem. Biophys. Res. Commun. 307 (2003) 254-260
57. Harrison B.C., et al. The CRM1 nuclear export receptor controls pathological cardiac gene expression. Mol. Cell. Biol. 24 (2004) 10636-10649
58. Gschwendt M., et al. Inhibition of protein kinase Cμ by various inhibitors. Differentiation from protein kinase C isoenzymes. FEBS Lett. 392 (1996) 77-80
59. Haworth R.S., and Avkiran M. Inhibition of protein kinase D by resveratrol. Biochem. Pharmacol. 62 (2001) 1647-1651
60. Pu Y., et al. A novel diacylglycerol-lactone shows marked selectivity in vitro among C1 domains of protein kinase C (PKC) isoforms α and δ as well as selectivity for RasGRP compared with PKCα. J. Biol. Chem. 280 (2005) 27329-27338
61. Mackay K., and Mochly-Rosen D. Localization, anchoring, and functions of protein kinase C isozymes in the heart. J. Mol. Cell. Cardiol. 33 (2001) 1301-1307
62. Zheng Y., et al. Phosphorylation of RasGRP3 on threonine 133 provides a mechanistic link between PKC and Ras signaling systems in B cells. Blood 105 (2005) 3648-3654
63. Luo B., et al. Association of diacylglycerol kinase ζ with protein kinase C α: spatial regulation of diacylglycerol signaling. J. Cell Biol. 160 (2003) 929-937